Antinociceptive effects of neuropeptide Y and related peptides in mice

被引:40
作者
Broqua, P
Wettstein, JG
Rocher, MN
GauthierMartin, B
Riviere, PJM
Junien, JL
Dahl, SG
机构
[1] Department of Pharmacology, Institut de Recherche Jouveinal, 94265 Fresnes
[2] Marion Merrell Dow Res. Institute, Strasbourg Research Center, 67080 Strasbourg, 16, rue d'Ankara
关键词
neuropeptide Y; neuropeptide Y receptor; antinociception; feeding; opioid receptor; alpha(2)-adrenoceptor; mouse;
D O I
10.1016/0006-8993(96)00262-4
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
This study compares the antinociceptive and orexigenic activities of NPY and analogs after intracerebroventricular administration in mice. NPY had an antinociceptive action in the mouse writhing test which was not affected by Drier treatment with naltrexone. yohimbine, idazoxan or reserpine. A detailed examination revealed that NPY (0.023-0.7 nmol), PYY (0.007-0.07 nmol), NPY2-36 (0.023-0.23 nmol) and the Y-1 agonist [Leu(31),Pro(34)]-NPY (0.07-0.7 nmol) all produced a dose-dependent and complete suppression of acetic acid-induced writhing. In contrast, the Y-2 agonist, NPY13-26, had little or no antinociceptive effect. As shown by their ED(50) values, the relative potency of the peptides was PYY > NPY2-36 greater than or equal to NPY > [Leu(31),Pro(34)]-NPY much greater than NPY13-36, suggesting that a Y-1 rather than a Y-2 or Y-3 receptor subtype was implicated in the antinociceptive action. Thereafter, all peptides were assessed for their effects on food intake. With respect to dose and peptide specificity, the hyperphagic effects of NPY and related peptides paralleled those on nociception, suggesting a common receptor mechanism. However, a purported NPY antagonist, [D-Trp(32)]-NPY, attenuated NPY's effect on feeding yet this same peptide elicited a dose-dependent inhibition of acetic acid-induced writhing, suggesting some molecular distinction between antinociception and stimulation of food intake.
引用
收藏
页码:25 / 32
页数:8
相关论文
共 50 条
[1]   NEUROPEPTIDE-Y DISTRIBUTION IN HUMAN-BRAIN [J].
ADRIAN, TE ;
ALLEN, JM ;
BLOOM, SR ;
GHATEI, MA ;
ROSSOR, MN ;
ROBERTS, GW ;
CROW, TJ ;
TATEMOTO, K ;
POLAK, JM .
NATURE, 1983, 306 (5943) :584-586
[2]   NEUROPEPTIDE-Y DISTRIBUTION IN THE RAT-BRAIN [J].
ALLEN, YS ;
ADRIAN, TE ;
ALLEN, JM ;
TATEMOTO, K ;
CROW, TJ ;
BLOOM, SR ;
POLAK, JM .
SCIENCE, 1983, 221 (4613) :877-879
[3]  
[Anonymous], 1993, BIOL NEUROPEPTIDE RE, DOI DOI 10.1007/978-1-59259-465-8_11
[4]   [D-TRP(32)]NEUROPEPTIDE-Y - A COMPETITIVE ANTAGONIST OF NPY IN RAT HYPOTHALAMUS [J].
BALASUBRAMANIAM, A ;
SHERIFF, S ;
JOHNSON, ME ;
PRABHAKARAN, M ;
HUANG, Y ;
FISCHER, JE ;
CHANCE, WT .
JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (06) :811-815
[5]  
BROQUA P, 1995, BEHAV PHARMACOL, V6, P215
[6]   THE ANATOMY OF NEUROPEPTIDE-Y-CONTAINING NEURONS IN RAT-BRAIN [J].
CHRONWALL, BM ;
DIMAGGIO, DA ;
MASSARI, VJ ;
PICKEL, VM ;
RUGGIERO, DA ;
ODONOHUE, TL .
NEUROSCIENCE, 1985, 15 (04) :1159-1181
[7]   NEUROPEPTIDE-Y - LOCALIZATION IN THE CENTRAL-NERVOUS-SYSTEM AND NEUROENDOCRINE FUNCTIONS [J].
DANGER, JM ;
TONON, MC ;
JENKS, BG ;
SAINTPIERRE, S ;
MARTEL, JC ;
FASOLO, A ;
BRETON, B ;
QUIRION, R ;
PELLETIER, G ;
VAUDRY, H .
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1990, 4 (03) :307-340
[8]   MICROINJECTION OF NEUROPEPTIDE-Y INTO THE SUPERFICIAL DORSAL HORN REDUCES STIMULUS-EVOKED RELEASE OF IMMUNOREACTIVE SUBSTANCE-P IN THE ANESTHETIZED CAT [J].
DUGGAN, AW ;
HOPE, PJ ;
LANG, CW .
NEUROSCIENCE, 1991, 44 (03) :733-740
[9]  
DUMONT Y, 1993, J NEUROSCI, V13, P73
[10]   GUANINE NUCLEOTIDE-BINDING PROTEIN GO-INDUCED COUPLING OF NEUROPEPTIDE Y-RECEPTORS TO CA-2+ CHANNELS IN SENSORY NEURONS [J].
EWALD, DA ;
STERNWEIS, PC ;
MILLER, RJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (10) :3633-3637